85 related articles for article (PubMed ID: 191259)
1. The role of leukocyte subpopulations in the indirect leukocyte adherence inhibition assay in the mammary tumor virus system.
Creemers P
Eur J Immunol; 1977 Jan; 7(1):48-53. PubMed ID: 191259
[TBL] [Abstract][Full Text] [Related]
2. Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice.
Gillette RW; Lowery LT
Cancer Res; 1976 Nov; 36(11 Pt 1):4008-14. PubMed ID: 184922
[TBL] [Abstract][Full Text] [Related]
3. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
[TBL] [Abstract][Full Text] [Related]
4. Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
Blair PB; Lane MA; Yagi MJ
J Immunol; 1975 Jul; 115(1):190-4. PubMed ID: 50346
[TBL] [Abstract][Full Text] [Related]
5. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
[TBL] [Abstract][Full Text] [Related]
6. Non-T cell killing of mammary tumor cells by spleen cells: secretion of antibody and recruitment of cells.
Blair PB; Lane MA
J Immunol; 1975 Jul; 115(1):184-9. PubMed ID: 168254
[TBL] [Abstract][Full Text] [Related]
7. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
[TBL] [Abstract][Full Text] [Related]
8. Micro-leukocyte adherence inhibition. I. Cellular basis of the mechanism of reactivity.
Russo AJ; Howell JH; Leveson SH; Holyoke ED; Goldrosen MH
J Immunol; 1978 Nov; 121(5):1914-9. PubMed ID: 81856
[TBL] [Abstract][Full Text] [Related]
9. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
Raina S; Russo AJ; Jenkins D; Goldrosen MH
Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
Trostmann H; Pfizenmaier K; Wagner H; Röllinghoff M
Transplantation; 1976 Jun; 21(6):446-53. PubMed ID: 1084606
[TBL] [Abstract][Full Text] [Related]
11. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
Blair PB; Lane MA; Yagi MJ
J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
[No Abstract] [Full Text] [Related]
12. The cellular mechanism of leukocyte adherence inhibition.
Koppi TA; Maluish AE; Halliday WJ
J Immunol; 1979 Nov; 123(5):2255-60. PubMed ID: 314958
[TBL] [Abstract][Full Text] [Related]
13. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
Lopez PF; Parks WP; Lopez DM
J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
[TBL] [Abstract][Full Text] [Related]
14. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
Stutman O
Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
[TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction.
Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Holyoke ED
Cancer Res; 1979 Feb; 39(2 Pt 2):587-92. PubMed ID: 367585
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
[TBL] [Abstract][Full Text] [Related]
17. Cellular and antigenic requirements for production of mixed leukocyte reaction suppressor factor.
Dennison DK; Rich SS; Rich RR
J Immunol; 1981 Nov; 127(5):2176-82. PubMed ID: 6457865
[TBL] [Abstract][Full Text] [Related]
18. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
Blair PB; Lane MA
J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
[TBL] [Abstract][Full Text] [Related]
19. Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus.
Lopez DM; Charyulu V; Sigel MM
Cancer Res; 1981 Mar; 41(3):813-8. PubMed ID: 6257384
[TBL] [Abstract][Full Text] [Related]
20. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
